Press Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel OK

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel OK

Get News Alerts by Email

Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Keywords Go

Advanced Search

Search

  Search Headlines Only

From

To

Asset Types

 Video  Audio  Photos  Documents  Events  Standard

 Basic Search

• Jul 17, 2012

  Trovagene, Inc., Announces Issuance of U.S. Patent for NPM Mutants to Diagnose and Monitor Acute Myeloid Leukemia
• Jul 2, 2012

  Trovagene to Study Trans-Renal KRAS Mutation Detection in Pancreatic Cancer

  Study will compare detection of KRAS mutations in urine to their detection in biopsy samples
• Jun 24, 2012

  Trovagene to be Added to Russell Microcap Index
• Jun 13, 2012

  Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.
• Jun 6, 2012

  Trovagene and Strand Life Sciences Plan Collaboration to Validate and Offer Urine-Based HPV Screening Test in India and South Asia

Show 5102550100 per page